Related references
Note: Only part of the references are listed.Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks - Candesartan Antihypertensive Survival Evaluation in Japan Trial
Toshio Ogihara et al.
HYPERTENSION (2008)
Management of atrial fibrillation
Gregory Y. H. Lip et al.
LANCET (2007)
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death -: The LIFE study
Kristian Wachtell et al.
CIRCULATION (2007)
Increased susceptibility to atrial tachyarrhythmia in spontaneously hypertensive rat hearts
Stephanie C. M. Choisy et al.
HYPERTENSION (2007)
Effects of normal blood pressure, prehypertension, and hypertension on coronary microvascular function
Dogan Erdogan et al.
CIRCULATION (2007)
Randomized study of angiotensin II type 1 receptor blocker vs dihydropiridine calcium antagonist for the treatment of paroxysmal atrial fibrillation in patients with hypertension - The J-RHYTHM II study design for the investigation of upstream therapy for atrial fibrillation
Takeshi Yamashita et al.
CIRCULATION JOURNAL (2006)
Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension
Peter M. Okin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Endothelial dysfunction: how can one intervene at the beginning of the cardiovascular continuum?
Roland E. Schmieder
JOURNAL OF HYPERTENSION (2006)
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study
J Heeringa et al.
EUROPEAN HEART JOURNAL (2006)
Losartan and prevention of atrial fibrillation recurrence in hypertensive patients
R Fogari et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
Rationale and design of the GISSI-Atrial Fibrillation trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence
Marcello Disertori et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2006)
Inflammation in the genesis and perpetuation of atrial fibrillation
MDM Engelmann et al.
EUROPEAN HEART JOURNAL (2005)
Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy?
A Choudhury et al.
EXPERT OPINION ON PHARMACOTHERAPY (2005)
Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers - A meta-analysis
JS Healey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol -: The Losartan Intervention For End point reduction in hypertension (LIFE) study
K Wachtell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Lifetime risk for development of atrial fibrillation - The Framingham Heart Study
DM Lloyd-Jones et al.
CIRCULATION (2004)
Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation
PL L'Allier et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating Telmisartan, Ramipril, and their combination in high-risk patients: The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials
KK Teo
AMERICAN HEART JOURNAL (2004)
Risks for atrial fibrillation and congestive heart failure in patients >= 65 years of age with abnormal left ventricular diastolic relaxation
TSM Tsang et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Association of QT interval with blood pressure in 80-year-old subjects
K Matsumura et al.
HYPERTENSION RESEARCH (2004)
Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease
A Boldt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation
K Kumagai et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation - The Strategies of Treatment of Atrial Fibrillation (STAF) study
J Carlsson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Atrial fibrillation in hypertension - Predictors and outcome
P Verdecchia et al.
HYPERTENSION (2003)
Angiotensin AT1/AT2 receptors: Regulation, signalling and function
E Kaschina et al.
BLOOD PRESSURE (2003)
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation
IC Van Gelder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
A comparison of rate control and rhythm control in patients with atrial fibrillation
DG Wyse et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women
TSM Tsang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study
S Stewart et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Vascular inflammation and the renin-angiotensin system
AR Brasier et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Progressive hypertrophy regression with sustained pressure reduction in hypertension:: the Losartan Intervention For Endpoint Reduction study
RB Devereux et al.
JOURNAL OF HYPERTENSION (2002)
Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure
YF Shi et al.
CARDIOVASCULAR RESEARCH (2002)
Change in diastolic left ventricular filling after one year of antihypertensive treatment -: The losartan intervention for endpoint reduction in hypertension (LIFE) study
K Wachtell et al.
CIRCULATION (2002)
Hypertension-related intermyocyte junction remodelling is associated with a higher incidence of low-K+-induced lethal arrhythmias in isolated rat heart
N Tribulova et al.
EXPERIMENTAL PHYSIOLOGY (2002)
Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure
DS Li et al.
CIRCULATION (2001)
Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients
B López et al.
CIRCULATION (2001)
Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
AS Go et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Prognostic implications of left ventricular hypertrophy
BA Vakili et al.
AMERICAN HEART JOURNAL (2001)
Rhythm or rate control in atrial fibrillation - Pharmacological intervention in atrial fibrillation (PIAF): a randomised trial
SH Hohnloser et al.
LANCET (2000)
Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans
A Goette et al.
CIRCULATION (2000)
Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation
H Nakashima et al.
CIRCULATION (2000)
Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation
A Goette et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Share Paper
